Contract Research & Services
Clinical Trials

Biomarkers: Recent Advances in Their Application to the Treatment of Hematologic Malignancies

Published 27 May 2015 | By Quintiles

Biomarkers hold promise in the diagnosis, prognosis and therapeutic stratification of hematopoietic malignancies. These heterogeneous diseases - including multiple myeloma, lymphomas and leukemias - are frequently characterized cytogenetically with diagnoses supported by genetic, immunohistochemical and flow cytometric analyses.

Available Downloads

Biomarkers: Recent Advances in Their Application to the Treatment of Hematologic Malignancies